ロード中...
Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile
BACKGROUND: Anamorelin HCl (ANAM) is a novel, orally active, ghrelin receptor agonist in clinical development for the treatment of cancer cachexia. We report in vitro and in vivo studies evaluating the preclinical pharmacologic profile of ANAM. METHODS: Fluorescent imaging plate reader and binding a...
保存先:
| 出版年: | J Cachexia Sarcopenia Muscle |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Berlin Heidelberg
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4248409/ https://ncbi.nlm.nih.gov/pubmed/25267366 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13539-014-0159-5 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|